DexCom Inc (NAS:DXCM)
$ 70.48 -1.32 (-1.84%) Market Cap: 27.53 Bil Enterprise Value: 28.14 Bil PE Ratio: 42.20 PB Ratio: 13.90 GF Score: 77/100

Q4 2022 Dexcom Inc Earnings Call Transcript

Feb 09, 2023 / 09:30PM GMT
Release Date Price: $107.24 (-2.37%)
Operator

Ladies and gentlemen, welcome to the Dexcom Fourth Quarter 2022 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call. (Operator Instructions) As a reminder, the conference is being recorded.

And I will now turn the call over to Sean Christensen, Vice President of Finance and Investor Relations. Sean, you may begin.

Sean Christensen
DexCom, Inc. - Director of Corporate Affairs & Head of IR

Thank you, Abby, and welcome to Dexcom's Fourth Quarter 2022 Earnings Call. Our agenda begins with Kevin Sayer, Dexcom's Chairman, President and CEO, who will summarize our recent highlights and ongoing strategic initiatives; followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer. Following our prepared remarks, we will open the call up for your questions. (Operator Instructions)

Please note that there are also slides available related to our fourth quarter performance on the Dexcom Investor Relations website on the Events and Presentations page.

With that, let's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot